five

A Phase II Study of Cetuximab Plus Irinotecan in Patients With EGFR-detectable Metastatic Colorectal Carcinoma

收藏
NIAID Data Ecosystem2026-03-06 收录
下载链接:
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2031612
下载链接
链接失效反馈
官方服务:
资源简介:
To evaluate the response rate of cetuximab plus irinotecan combination therapy in subjects with EGFR-detectable metastatic colorectal carcinoma who have documented progressive disease to irinotecan-based chemotherapy and who have failed (progressive disease or intolerance) previous oxaliplatin-based and fluoropyrimidine-based chemotherapies.
创建时间:
2005-10-15
二维码
社区交流群
二维码
科研交流群
商业服务